“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.
B vitamin sold for hair and nails. No randomised trial has tested its effect on hair, and it can distort numerous blood tests.
Biotin skews numerous blood tests: in 6 healthy adults, 10 mg per day for 7 days skewed 9 of the 23 assays studied. One patient thus presented false Graves' disease results, which returned to normal upon stopping biotin. In a survey, 7.7% of patients interviewed at consultation were taking it, and 7.4% of samples taken in the emergency department contained enough to skew certain tests. Inform your doctor and the laboratory before a blood test. For troponin, the heart attack marker, the risk of a false result was deemed extremely low in two patient cohorts. Also worth knowing: no randomized trial has tested biotin on hair loss or quality in humans, and its popularity far exceeds the evidence. In progressive multiple sclerosis, the first trial was positive, but the large phase 3 trial (642 patients) showed no effect on disability or walking. Diabetes trials test biotin with chromium, which makes it impossible to know which of the two acts.
2 mg per day, with chromium picolinate, in diabetes trials; no dose tested in a controlled trial for hair or nails.
In the first trial on progressive multiple sclerosis, 12.6% of patients on a very high dose of biotin (300 mg per day) saw their disability decrease, compared to none on placebo. The subsequent trial, four times larger, found nothing.
This phase 3, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of high-dose biotin (100 mg, three times daily) in 642 patients with progressive multiple sclerosis. The study showed no significant improvement in disability or walking speed compared to placebo. In addition, biotin led to inaccurate laboratory results and is therefore not recommended for the treatment of progressive multiple sclerosis.
Cree BAC, Cutter G, Wolinsky JS, Freedman MS, Comi G, Giovannoni G, Hartung HP, Arnold D, Kuhle J, Block V, Munschauer FE, Sedel F, Lublin FD, SPI2 investigative teams. — The Lancet. Neurology (2020) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more